Standardized treatment planning methodology for passively scattered proton craniospinal irradiation

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Giebeler, Annelise ^a,b,c   Newhauser, Wayne D ^a,b,d   Amos, Richard A ^a,b   Mahajan, Anita ^a   Homann, Kenneth ^a,b   Howell, Rebecca M ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c Scripps Proton Therapy Center   (United States)

^d LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Craniospinal irradiation; CSI; Medulloblastoma; Proton

Indexed keywords

ADOLESCENT; ARTICLE; BRAIN; CANCER RADIOTHERAPY; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOSPINAL IRRADIATION; DOSIMETRY; ESOPHAGUS; EYE; FEMALE; HEART; HISTOGRAM; HOSPITALIZED CHILD; HUMAN; INTERMETHOD COMPARISON; KIDNEY; LENS; LIVER; LUNG; MALE; PRESCHOOL CHILD; PROTON THERAPY; RADIOSENSITIVITY; SCATTERED PROTON CRANIOSPINAL IRRADIATION; SCHOOL CHILD; SPINAL CORD; STANDARDIZATION; THYROID GLAND; TREATMENT PLANNING; VERTEBRA BODY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CRANIOSPINAL IRRADIATION; FEMALE; HUMANS; MALE; PHOTONS; PLANNING TECHNIQUES; PROGNOSIS; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL;

EID: 84873054405     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-32     Document Type: Article

References (39)

1. Olsen DR. Proton therapy - a systematic review of clinical effectiveness. Radiother Oncol 2007, 83(2):123-132. 10.1016/j.radonc.2007.03.001, 17499374.
2. Goozner M. The proton beam debate: are facilities outstripping the evidence?. J Natl Cancer Inst 2010, 102(7):450-453. 10.1093/jnci/djq112, 20339139.
3. Brada M, Pijls-Johannesma M, De Ruysscher D. Current clinical evidence for proton therapy. Cancer J 2009, 15(4):319-324. 10.1097/PPO.0b013e3181b6127c, 19672149.
4. Hall EJ. Is there a place for quantitative risk assessment?. J Radiol Prot 2009, 29(2A):A171-A184. 10.1088/0952-4746/29/2A/S12, 19454800.
5. Merchant TE. Proton beam therapy in pediatric oncology. Cancer J 2009, 15(4):298-305. 10.1097/PPO.0b013e3181b6d4b7, 19672146.
6. Newhauser WD, Durante M. Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer 2011, 11(6):438-448. 10.1038/nrc3069, 21593785.
7. St Clair WH. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 2004, 58(3):727-734. 10.1016/S0360-3016(03)01574-8, 14967427.
8. Taddei PJ. Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation. Phys Med Biol 2010, 55(23):7067-7080. 10.1088/0031-9155/55/23/S08, 3001324, 21076189.
9. Yoon M. Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. Int J Radiat Oncol Biol Phys 2011, 81(3):637-646. 10.1016/j.ijrobp.2010.06.039, 20932690.
10. Yuh GE. Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children. Cancer J 2004, 10(6):386-390. 10.1097/00130404-200411000-00009, 15701271.
11. Hansen EK, Roach M. Handbook of evidence-based radiation oncology 2010, New York: Springer.
12. Yock TI. Pediatric tumors 2008, Philadelphia: Lippincott Williams and Wilkins.
13. Woo S. Rationale for Proton Therapy in Pediatric Malignancies. Ion Beam Therapy 2012, 277-286. Berlin Heidelberg: Springer, Linz U.
14. Lee CT. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?. Int J Radiat Oncol Biol Phys 2005, 63(2):362-372. 10.1016/j.ijrobp.2005.01.060, 16168831.
15. Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer 2007, 121(10):2233-2240. 10.1002/ijc.22827, 17557301.
16. Terasawa T. Systematic review: charged-particle radiation therapy for cancer. Ann Intern Med 2009, 151(8):556-565.
17. Lodge M. A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiother Oncol 2007, 83(2):110-122. 10.1016/j.radonc.2007.04.007, 17502116.
18. Brada M, Pijls-Johannesma M, De Ruysscher D. Proton therapy in clinical practice: current clinical evidence. J Clin Oncol 2007, 25(8):965-970. 10.1200/JCO.2006.10.0131, 17350945.
19. Durante M, Loeffler JS. Charged particles in radiation oncology. Nat Rev Clin Oncol 2010, 7(1):37-43. 10.1038/nrclinonc.2009.183, 19949433.
20. Yom SS. Field-in-field technique with intrafractionally modulated junction shifts for craniospinal irradiation. Int J Radiat Oncol Biol Phys 2007, 69(4):1193-1198. 10.1016/j.ijrobp.2007.04.062, 17967308.
21. Bentel G. Radiation therapy planning: Including problems and solutions 1996, New York: McGraw-Hill, Health Professions Division.
22. Vann A. Portal design in radiation therapy 2006, Columbia: R.L. Bryan Co.
23. Newhauser W. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm. Phys Med Biol 2007, 52(15):4569-4584. 10.1088/0031-9155/52/15/014, 17634651.
24. Smith A. The M. D. Anderson proton therapy system. Med Phys 2009, 36(9):4068-4083. 10.1118/1.3187229, 19810479.
25. Schaffner B. Proton dose calculation based on in-air fluence measurements. Phys Med Biol 2008, 53(6):1545-1562. 10.1088/0031-9155/53/6/003, 18367787.
26. ICRU ICRU report 78 - prescribing, recording, and reporting proton-beam therapy. Vol. 7(2) 2007, Bethesdam: International Commission on Radiation Units and Measurements, ICRU.
27. Bussiere MR, Adams JA. Treatment planning for conformal proton radiation therapy. Technol Cancer Res Treat 2003, 2(5):389-399.
28. Dong L. A digital couch solution for treatment planning beams through the treatment couch PTCOG, Vol. 46 2006, China: Wanjie.
29. Kim JS. Modeling of a digital couch for a proton treatment planning system. J Korean Phys Soc 2009, 55(4):1640-1648.
30. Newhauser WD. Can megavoltage computed tomography reduce proton range uncertainties in treatment plans for patients with large metal implants?. Phys Med Biol 2008, 53(9):2327-2344. 10.1088/0031-9155/53/9/009, 18421122.
31. Howell RM. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma. Radiat Oncol 2012, 7:116. 10.1186/1748-717X-7-116, 3430590, 22828073.
32. Brodin NP. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol 2011, 50(6):806-816. 10.3109/0284186X.2011.582514, 21767178.
33. Zhang X. Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int J Radiat Oncol Biol Phys 2007, 67(2):620-629. 10.1016/j.ijrobp.2006.10.008, 1945214, 17236979.
34. Moyers MF, Miller DW. Range, range modulation, and field radius requirements for proton therapy of prostate cancer. Technol Cancer Res Treat 2003, 2(5):445-447.
35. Moyers MF. Methodologies and tools for proton beam design for lung tumors. Int J Radiat Oncol Biol Phys 2001, 49(5):1429-1438. 10.1016/S0360-3016(00)01555-8, 11286851.
36. Urie M, Goitein M, Wagner M. Compensating for heterogeneities in proton radiation therapy. Phys Med Biol 1984, 29(5):553-566. 10.1088/0031-9155/29/5/008, 6330772.
37. Lunsford TR, Lunsford BR. The research sample, part I: sampling. J Prosthetics Orthotics 1995, 7(3):105-112.
38. Miralbell R. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002, 54(3):824-829. 10.1016/S0360-3016(02)02982-6, 12377335.
39. Newhauser WD. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol 2009, 54(8):2277-2291. 10.1088/0031-9155/54/8/002, 19305036.